Raia Drogasil SA (OTCPK:RADLY)

$ 4.02 0.28 (7.49%) Market Cap: 6.90 Bil Enterprise Value: 7.62 Bil PE Ratio: 36.22 PB Ratio: 7.05 GF Score: 85/100

Q3 2024 Raia Drogasil S/A Earnings Call Transcript
Nov 06, 2024

$4.5 (+8.17%)

Earnings
Q2 2024 Raia Drogasil S/A Earnings Call Transcript
Aug 07, 2024

$5.1 (-5.03%)

Earnings
Q3 2023 Raia Drogasil S/A Earnings Call Transcript
Nov 01, 2023

$4.83 (-4.27%)

Earnings
Q2 2023 Raia Drogasil SA Earnings Call Transcript
Aug 09, 2023

$5.31 (-2.21%)

Earnings
Q1 2023 Raia Drogasil SA Earnings Call Transcript
May 03, 2023

$5.1

Earnings
Q4 2022 Raia Drogasil SA Earnings Call Transcript
Mar 08, 2023

$5.37 (-3.77%)

Earnings
Q3 2022 Raia Drogasil SA Earnings Call Transcript
Nov 01, 2022

$4.41

Earnings
Q2 2022 Raia Drogasil SA Earnings Call Transcript
Aug 01, 2022

$3.72

Earnings
Q1 2022 Raia Drogasil SA Earnings Call Transcript
May 04, 2022

$4 (-2.68%)

Earnings
Q4 2021 Raia Drogasil SA Earnings Call Transcript
Feb 23, 2022

$4.68

Earnings
Q3 2021 Raia Drogasil SA Earnings Call Transcript
Nov 10, 2021

$4.21

Earnings
Raia Drogasil SA Day Transcript
Oct 28, 2021
Q2 2021 Raia Drogasil SA Earnings Call Transcript
Aug 11, 2021

$4.86 (-3.76%)

Earnings
Q1 2021 Raia Drogasil SA Earnings Call Transcript
May 12, 2021

$4.9 (-6.24%)

Earnings
Q4 2020 Raia Drogasil SA Earnings Call Transcript
Mar 10, 2021

$4.28 (+9.21%)

Earnings
Q3 2020 Raia Drogasil SA Earnings Call Transcript
Oct 28, 2020

$4.25 (-9.59%)

Earnings
Q2 2020 Raia Drogasil SA Earnings Call Transcript
Aug 12, 2020

$4.11 (-9.08%)

Earnings
Q1 2020 Raia Drogasil SA Earnings Call Transcript
Apr 29, 2020

$4.01 (+6.54%)

Earnings
Q4 2019 Raia Drogasil SA Earnings Call Transcript
Feb 20, 2020

$5.42 (-1.20%)

Earnings
Q3 2019 Raia Drogasil SA Earnings Call Transcript
Oct 30, 2019

$5.4

Earnings
Q2 2019 Raia Drogasil SA Earnings Call Transcript
Aug 07, 2019

$4.97

Earnings
Q1 2019 Raia Drogasil SA Earnings Call Transcript
Apr 30, 2019

$3.45 (+1.53%)

Earnings
Q4 2018 Raia Drogasil SA Earnings Call Transcript
Feb 27, 2019

$3.98 (+5.46%)

Earnings

Q4 2019 Raia Drogasil SA Earnings Call Transcript

Feb 20, 2020 / 03:00PM GMT

Release Date Price: $5.42 (-1.20%)

Transcript

Operator

Good morning, ladies and gentlemen. At this time, we would like to welcome everyone to RD People, Health and Well-being conference call to discuss its 4Q '19 results. The audio for this conference is being broadcast simultaneously for the Internet in their website, www.rd.com.br/ir. In that address, you can also find a slide show presentation available for download. (Operator Instructions)

Before proceeding, let me mention that forward-looking statements are being made under the safe harbor of Securities Ligation Reform Act of 1996 (sic) [1995]. Forward-looking statements are based on the beliefs and assumptions of RD management and on information currently available for the company. Forward-looking statements are not guarantees of performance. They involve risks, uncertainties and assumptions because they relate to the future events and therefore depend on circumstances that may or may not occur in the future. Investors should understand that general economic conditions, industry conditions and other operating factors could also

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.